Lupin 2024

Steven Selde

Steven Selde joins AAM’s Biosimilars Council as director

Steven Selde joins AAM’s Biosimilars Council as director

WASHINGTON  – Steven Selde has joined the Association for Accessible Medicines (AAM) as director of the Biosimilars Council. This division of AAM educates the public and patients about the safety and effectiveness of biosimilars, focusing on access, the regulatory environment, reimbursement and legal affairs. Member organizations include manufacturers and stakeholders working to develop biosimilar products

PP_1170x120_10-25-21